Northwestern Mutual Wealth Management
DMAC icon

Northwestern Mutual Wealth Management’s DiaMedica Therapeutics DMAC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35 Hold
5
– – ﹤0.01% 4031
2026
Q1 		$34 Buy
+5
New +$40 ﹤0.01% 4050

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northwestern Mutual Wealth Management's DMAC Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 5 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #4031.

Northwestern Mutual Wealth Management first reported a position in DMAC in Q1 2026 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Northwestern Mutual Wealth Management held 5 shares of DiaMedica Therapeutics worth $35 as of Q2 2026.
  • Northwestern Mutual Wealth Management left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4031 holding.
  • Northwestern Mutual Wealth Management first reported a position in DiaMedica Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.